Immunomodulation in sepsis;Immunmodulation in der Sepsis

Chirurg

Volumn 73, Issue 11, 2002, Pages 1100-1104

  Hoflich C ^a   Volk, H D ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Immunocompetence; Immunomonitoring; Immunoreconstitution; Sepsis

Indexed keywords

IMMUNOLOGICAL ADJUVANT;

ANIMAL; CELLULAR IMMUNITY; DRUG EFFECT; HUMAN; IMMUNOCOMPETENCE; IMMUNOLOGY; PHYSIOLOGY; PILOT STUDY; REVIEW; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; HUMANS; IMMUNITY, CELLULAR; IMMUNOCOMPETENCE; PILOT PROJECTS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 4243332665     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00104-002-0559-5     Document Type: Article

References (16)

1. Abbas AK, Lichtman AH, Pober JS (1994) Cellular and molecular immunology. Saunders, Philadelphia
2. Landmann R, Muller B, Zimmerli W (2000) CD14, new aspects of ligand and signal diversity. Microbes Infect 2:295
3. Spits H, de Waal Malefyt R (1992) Functional characterization of human IL-10. Int Arch Allergy Immunol 99:8
4. Barker RN, Erwig L, Pearce WP, Devine A, Ress AJ (1999) Differential effects of necrotic or apoptotic cell uptake on antigen presentation by macrophages. Pathobiology 67:302
5. Kox WJ, Volk T, Kox SN, Volk HD (2000) Immunomodulatory therapies in sepsis. Intensive Care Med 26 [Suppl 1]:S124
6. Woiciechowsky C, Schoning B, Lanksch WR, Volk HD, Docke WD (1999) Mechanisms of brain-mediated systemic anti-inflammatory syndrome causing immunodepression. J Mol Med 77:769
7. Döcke, WD, Randow F, Syrbe U et al. (1997) Monocyte deactivation in septic patients7 restoration by IFN-γ treatment. Nat Med 3:678
8. Williams MA, Withington S, Newland AC, Kelsey SM (1998) Monocyte anergy in septic shock is associated with a predilection to apoptosis and is reversed by granulocyte-macrophage colony-stimulating factor ex vivo. J Infect Dis 178:1421
9. Reinke P, Döcke WD, Syrbe U et al. (1994) Einsatz von Blutreinigungsverfahren bei Sepsis auf der Basis neuer Erkenntnisse zur Immunpathogenese der Sepsis. In: Riedel W (Hrsg) Kontinuierliche Blutreinigungsverfahren in der Intensivtherapie. Pabst, Lengerich, S23
10. Agnes A, Zippel K, Zuckermann H, Doecke WD, Volk HD, Mueller JM (1998) Immune stimulation with G-CSF (Neupogen) in septic patients with immune paralysis. Langenbecks Arch Chir [Suppl Kongressbd] 115:1077
11. Schumann RR, Zweigner J (1999) A novel acute-phase marker: lipopolysaccharide binding protein (LBP). Clin Chem Lab Med 37:271
12. Steinbach G, Grunert A (1998) Procalcitonin - a new indicator for bacterial infections. Exp Clin Endocrinol Diabetes 106:164
13. Redl H, Schiesser A, Jogel E, Assicot M, Bohuon C (2001) Possible role of TNF on procalcitonin release in a baboon model of sepsis. Shock 16:25
14. Sabat R, Höflich C, Döcke WD et al. (2001) Massive elevation of procalcitonin plasma levels in the absence of infection in kidney transplant patients treated with pan-T-cell antibodies. Intensive Care Med 27:987
15. Selberg O, Hecker H, Martin M, Klos A, Bautsch W, Kohl J (2000) Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6. Crit Care Med 28:2793
16. Volk HD, Thieme M, Ruppe U et al.(1993) Alterations in function and phenotype of monocytes from patients with septic disease: predictive value and new therapeutic strategies. In: Faist E, Meakins JL (eds) Host defense dysfunction in trauma, shock and sepsis. Springer, Berlin Heidelberg New York Tokyo, p 246